Olivier Menage
CEO/Marketing/Strategy
Experience
Jan 2022 - Present
2 years 2 monthsCo-founder and CEO
PEYEONEER MEDTECH
- Co-founded and steered a pioneering healthcare startup in collaboration with Maastricht University. Defined and executed the company's vision, focusing on innovative glaucoma treatment implants.
- Conducted extensive market research to understand competitive landscapes and consumer needs. Developed a comprehensive strategy for product positioning and market entry, particularly targeting the US market.
- Led the development of market access and regulatory strategies, adapting to the dynamic healthcare environment. Spearheaded preparations for initial clinical trials in the United States.
- Successfully negotiated with tech transfer offices, ensuring the protection and commercial viability of product innovations.
Jan 2022 - Dec 2023
1 yearVP Marketing International
WALLABY PHENOX
- Championed the development and execution of international marketing strategies, leading to the successful launch of products across 60 countries. Ensured longevity and market relevance through strategic planning.
- Played a critical role in comprehensive market research initiatives, contributing to the seamless integration of Phenox and Wallaby into the Medtech Europe Neurovascular Tracker.
- Led a significant rebranding initiative for WallabyPhenox, receiving unanimous board approval. This initiative played a key role in strengthening the brand's position in the market.
- Worked closely with Clinical Affairs and Market Access teams to refine clinical claims and develop effective reimbursement strategies, enhancing product credibility and adoption.
Jan 2020 - Present
5 years 2 monthsCo-founder and CEO
MONA.health
- Established an innovative healthcare startup, focusing on the application of artificial intelligence for large-scale eye disease screening. This venture, in partnership with VITO and KU Leuven, positioned MONA.health as a leader in digital health innovation.
- Directed the development of AI-driven solutions targeting diabetic retinopathy. Successfully navigated the regulatory landscape to secure CE mark approval, demonstrating compliance with European health and safety standards.
- Successfully raised €1.5 million in seed funding and secured an additional €250k in non-dilutive financing, underlining the project's viability and potential for growth.
- Assembled and led a dedicated team of professionals, focusing on expanding the startup's reach across Europe. Developed strategies for market penetration and customer engagement.
- Forged strategic partnerships for commercialization and research. Notably collaborated with Fujitsu in the UK, enhancing the company's research capabilities and market presence.
Jan 2016 - Dec 2020
3 yearsMarketing Director EMEA
ABBOTT
Market leader in coronary and peripheral artery disease, EMEA sales $1bn
- Led a dynamic team of 18, overseeing product marketing, communications, and training initiatives.
- Orchestrated the successful repositioning and launch of Xience Sierra, achieving significant market share growth. 136% above expectations, 3% market share increase (28% to 31% in 6 months)
- Formulated therapy development strategies, resulting in a 30% annual revenue surge.
- Exceeding plan by $12m
- Modernized communication channel mix with video and targeted digital content
Jan 2015 - Dec 2017
3 yearsMarketing Director Minimally Invasive Surgery Expansion EMEA
MEDTRONIC
Global leader in surgical devices, $2 billion EMEA sales
- Drove the adoption of minimally invasive surgery techniques in EMEA, achieving a 20% increase in adoption rates over 5 years.
- innovative solutions and new educational programs
- Pioneered strategies to transition from a device-centric approach to a holistic solutions provider.
- Developed innovative business models to establish centers of excellence for minimally invasive surgery.
Jan 2010 - Dec 2015
5 yearsDirector Procedural Marketing Bariatric Surgery EMEA
COVIDIEN
- Transformed a traditional transactional go-to-market model into a solution selling model.
- Developed and implemented a new business model based on innovative consulting services to obesity centers, driving $12M in incremental annual growth.
- Managed a team of 17 obesity specialists in Europe
- Winner of the 2014 Covidien Innovation Award, Business Model
- Designed and implemented e-health platform with connected device to improve patient journey beforehand after surgery
- Developed partnerships with patient organizations across Europe
- Re-launched European Obesity Day through a pan-European PR campaign with KOLs and patients
Jan 2009 - Dec 2011
3 yearsMarketing Director Energy Based Device EMEA
COVIDIEN
- Developed thoracic surgery market in Europe, launched LigaSure for lobectomy
- Pursue regulatory process to obtain CE Mark for thoracic indication
- Conducted the Ligasure 2 clinical study, a controlled, randomized, multi-center Phase 3 study in France comparing LigaSure to stapling in lobectomy.
Jan 2007 - Dec 2009
2 yearsHead of Healthcare Policies and Payments Europe
ACCURAY
- Managed the establishment of DRGs in France, Switzerland, Germany and Italy
- Developed and implemented strategies to accelerate reimbursement for CyberKnife procedures through partnerships with clinicians and national healthcare payers
Jan 2002 - Dec 2008
6 yearsSenior Customer Programs Manager Cardiology International
BOSTON SCIENTIFIC
- Designed and implemented the first interventional cardiology registry with clinical monitoring for the launch of the TAXUS stent: Milestone I and II (6192 patients, 164 sites, 31 countries).
- Led the strategic development of international advisory boards
- Partnered with the European Society of Cardiology (ESC) to include the TAXUS stent in new guidelines
Jan 1999 - Dec 2003
3 yearsPricing Manager Cardiology and Endosurgery Europe
BOSTON SCIENTIFIC
Led the pricing strategy for the European launch of the TAXUS Drug Eluting Stent, resulting in a 60% market share 6 months after launch.
Jan 1997 - Dec 1999
3 yearsFinancial Controller France
LIFESCAN
- Led financial planning and analysis and managed customer service.
- Initiated and led a major re-engineering of the pricing structure to comply with French regulatory requirements following an antitrust investigation.
Jan 1993 - Dec 1997
3 yearsFinancial and Operations Analyst
JOHNSON & JOHNSON CONSUMER
Manages the distributors for J&J consumer in 25 countries
- Orchestrated the management of distributors across 25 countries, ensuring seamless operations and optimal distribution strategies.
- Spearheaded logistics coordination among 20 different plants worldwide, conducting comprehensive sourcing analyses that culminated in the strategic recommendation of Athens as the global distribution center.
- Led a European task force comprising 10 members, successfully consolidating the production of lip care sticks from five sites to one, resulting in annual cost savings of $1.2 million.
- Innovatively designed and implemented a risk policy for credit management, effectively reducing overdue payments by 20%, equivalent to a value of $5 million.
Summary
Seasoned Healthcare Executive with over 25 years of global leadership in healthcare management and innovation, aiming to lead the Medical Business Unit at Materialise. Bringing a strong background in strategic planning, commercialization of medical devices, and team development to drive long-term strategic goals and market growth.
- Strategic Leadership in Healthcare
- Commercialization of Medical Devices in US and EU
- Cross-Functional Team Management and Coaching
- Financial Planning and Budget Management
- Market Analysis and Growth Opportunity Identification
- Product and Service Evolution Knowledge
- Strong Interpersonal and Stakeholder Relationship Skills
- Proactive and Entrepreneurial Mindset
Languages
French
Native
English
Advanced
Education
Oct 1987 - Jun 1994